Incyte (INCY)
(Real Time Quote from BATS)
$56.86 USD
-0.19 (-0.33%)
Updated May 16, 2024 03:57 PM ET
After-Market: $56.87 +0.01 (0.02%) 4:14 PM ET
3-Hold of 5 3
B Value D Growth D Momentum D VGM
Revenue - Line of Business Segments | YR Estimate | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|---|
Royalty revenues: Tabrecta [$M] |
-- | 18 | 15 | 10 | 4 | -- |
Revenues: Product revenues [$M] |
-- | 3,165 | 2,747 | 2,322 | 2,069 | 1,775 |
Revenues: Product royalty revenue... |
-- | 523 | 483 | 569 | 393 | 306 |
Milestone and contract revenues [... |
-- | 7 | 165 | 95 | 205 | 78 |
Net product revenues: Jakafi [$M] |
-- | 2,594 | 2,409 | 2,135 | 1,938 | 1,685 |
Net product revenues: Iclusig [$M... |
-- | 112 | 106 | 109 | 105 | 90 |
Net product revenues: Pemazyre [$... |
-- | 84 | 83 | 69 | 26 | -- |
Net product revenues: Minjuvi [$M... |
-- | 37 | 20 | 5 | -- | -- |
Net product revenues: Opzelura [$... |
-- | 338 | 129 | 5 | -- | -- |
Royalty revenues: Jakavi [$M] |
-- | 368 | 332 | 338 | 278 | 226 |
Royalty revenues: Olumiant [$M] |
-- | 136 | 135 | 221 | 111 | 80 |